GAD Antikörper (N-Term)
Kurzübersicht für GAD Antikörper (N-Term) (ABIN928718)
Target
Alle GAD (GAD1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Maus
-
Aufreinigung
- Purified
-
Immunogen
- Gad1 antibody was raised in rabbit using the N terminal of Gad1 as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
Gad1 Blocking Peptide, (ABIN5613700), is also available for use as a blocking control in assays to test for specificity of this Gad1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- GAD (GAD1) (Glutamate Decarboxylase 1 (Brain, 67kDa) (GAD1))
-
Andere Bezeichnung
- Gad1
-
Hintergrund
- This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Synonyms: Polyclonal Gad1 antibody, Anti-Gad1 antibody, glutamic acid decarboxylase 1 antibody.
Target
-